Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
cancer
cancer drugs
5
×
life sciences
national blog main
san francisco blog main
clinical trials
national top stories
san francisco top stories
eli lilly
ipo
amgen
black diamond therapeutics
blueprint medicines
deals
europe blog main
fda
genentech
indiana blog main
indiana top stories
loxo oncology
non-small cell lung cancer
revolution medicines
roche
san francisco
sanofi
the column group
third rock ventures
warp drive bio
adaptive biotechnologies
alector
allergan
apollomics
avapritinib
bernie sanders
beta bionics
bill & melinda gates foundation trust
bladder cancer
What
cancer
5
×
medicines
drug
ipo
research
black
pharmaceutical
proteins
revolution
targets
address
appetite
approval
approves
bio
biotech
blueprint
bread
butter
buyout
cancer’s
carries
cash
certain
clinic
companies
designed
despite
diabetes
diamond
diamond’s
disease
drugs
eli
eluded
family
fda
frontiers
genetic
giant
Language
unset
Current search:
cancer
×
" cancer drugs "
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More